A Single Domain–Based Anti-Her2 Antibody Has Potent Antitumor Activities
Author:
Funder
Department of Science and Technology of Guangdong Province
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference39 articles.
1. Targeting HER2+breast cancer cells: lysosomal accumulation of anti-HER2 antibodies is influenced by antibody binding site and conjugation to polymeric nanoparticles;Owen;J Control Release,2013
2. The distinctive nature of HER2-positive breast cancers;Burstein;N Engl J Med,2005
3. HER2 testing in gastric cancer: a practical approach;Ruschoff;Mod Pathol,2012
4. Critical appraisal of trastuzumab in treatment of advanced stomach cancer;Meza-Junco;Cancer Manag Res,2011
5. Molecular characterization of apocrine salivary duct carcinoma;Chiosea;Am J Surg Pathol,2015
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development of a new affinity maturation protocol for the construction of an internalizing anti-nucleolin antibody library;Scientific Reports;2024-05-08
2. A novel nanobody-based HER2-targeting antibody exhibits potent synergistic antitumor efficacy in trastuzumab-resistant cancer cells;Frontiers in Immunology;2023-10-25
3. Reviving a Classic Antigen with a Cutting-Edge Approach: Nanobodies for HER2+ Breast Cancer;Pharmaceuticals;2023-05-26
4. A novel multifunctional anti-PD-L1-CD16a-IL15 induces potent cancer cell killing in PD-L1-positive tumour cells;Translational Oncology;2022-07
5. Angiogenic biomolecules specific nanobodies application in cancer imaging and therapy; review and updates;International Immunopharmacology;2022-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3